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In-cell NMR spectroscopy is a unique tool to characterize biological macromolecules in their physiological 
environment at atomic resolution. Recent progresses of NMR instruments and sample preparation methods allow 
functional processes, such as metal uptake, disulfide bond formation, protein folding, to be analyzed by NMR in 
living, cultured human cells. This protocol describes the necessary steps to overexpress one or more proteins of 
interest inside human HEK293T cells and explains how to setup in-cell NMR experiments. The cDNA is transiently 
transfected as a complex with a cationic polymer, and protein expression is carried on for 2-3 days, followed by 
the NMR sample preparation. 1H and 1H-15N SOFAST-HMQC NMR experiments can be acquired in less than 2 
hours, ensuring cell viability. Uniform 15N labeling and amino acid specific (e.g. cysteine, methionine) labeling 
schemes are possible. The entire procedure takes 4 days from cell culture seeding to NMR data collection.  
 
INTRODUCTION 
In-cell NMR spectroscopy allows the study of 
biomolecules, in particular proteins, inside living cells. 
It is therefore a powerful method for acquiring structural 
and functional information of biomolecules at atomic 
resolution in their natural, physiological environment1–
5. In-cell NMR has been successfully employed on 
bacterial cells to analyze protein structure6, dynamics7,8 
and interactions9–11. Although prokaryotic cells have 
some advantages, like being easy to handle, growing 
fast, and expressing exogenous proteins at high levels, 
to be meaningful eukaryotic proteins should be 
characterized in eukaryotic cells. Indeed, prokaryotic 
organisms exhibit a limited range of biological activities 
and many of the cellular processes that define the 
challenging questions in biological research are absent 
in bacteria. Post-translational protein modifications 
regulate biological activities in eukaryotes, but are much 
less common in prokaryotic organisms. The presence of 
organelles and the requirement of regulated cellular 
transport constitutes another characteristic of eukaryotic 
cells. Compartmentalization causes the creation of sub-
cellular environments with different physical and 
biological properties and the effects that these 
compartments exert on the protein conformation, state 
and/or function need to be properly addressed. 
To date, several approaches have been used to have 
the proteins of interest properly labeled and located 
inside the cytoplasm of eukaryotic cells. Microinjection, 
cell-penetrating peptides, pore-forming toxin, and 
electroporation have been the most commonly used 
methods3,10,12–14. The large size of Xenopus laevis 
oocytes allows microinjection of isotopically labeled 
proteins, produced in bacteria, into the cytosol12. In this 
system, proteins phosphorylation and structures of 
nucleic acids have been investigated15–18. Alternatively, 
the isotopically labeled proteins could be delivered into 
the eukaryotic cytoplasm via CPP (cell-penetrating 
peptides) covalently linked to the protein. The proteins 
are subsequently released from CPP by endogenous 
enzymatic action or by autonomous reductive cleavage3. 
Ogino et al. exploited the pore-forming toxin 
streptolysin O to import the protein thymosin β4 in 
human cells13. One advantage of this approach, in 
contrast to the CPP strategy, is that no modifications to 
the protein are required for intracellular sample 
delivery19. Recently, protein electroporation has been 
developed; this approach involves applying an electric 
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pulse to cells so to insert the purified protein of interest 
into the cytosol10,14.  
All these methods rely on heterologous protein 
expression and purification, and its subsequent insertion 
in the cell. This implies that several aspects cannot be 
easily addressed, such as the steps of protein maturation 
including folding, cofactor binding, cysteine oxidation 
etc., as the proteins expressed and purified from 
bacterial cells are already folded/oxidized and usually 
need additional treatment prior to insertion, making 
harder to obtain meaningful information from in-cell 
NMR data. Therefore, a strategy for producing, labeling 
and studying proteins directly in eukaryotic cells is 
desirable. Intracellular expression strategies for in-cell 
NMR have been successfully applied to yeast and insect 
cells20,21. Such approaches would be especially suited 
for proteins that 1) have tendency to aggregate in vitro 
at high concentrations; 2) undergo co-translational 
processes for correct folding or intracellular targeting; 
3) are sensitive to the redox properties of the 
environment (e.g. require thiol-based reducing agents 
and/or absence of oxygen). Furthermore, human 
proteins should be investigated in a human cellular 
environment, to closely match the physiological 
conditions in terms of molecular composition. 
Here, we describe the step-by-step procedure for the 
preparation of samples of Human Embryonic Kidney 
293T (HEK293T) cells expressing isotopically labeled 
proteins, and for the recording of in-cell NMR 
experiments. This protocol relies on transiently 
transfecting the cells with one or more genes of interest, 
using a vector designed for high level constitutive 
cytoplasmic protein expression. Isotope labeling is 
performed by providing a growth medium isotopically 
labeled at the time of transfection. Co-transfection of 
two or more genes can be performed, resulting in the 
simultaneous expression and labeling of the proteins. 
After protein expression, in-cell NMR data is collected 
to obtain information on the intracellular conformation 
of the protein(s). Compared to the protein insertion 
strategies, intracellular expression has the advantage of 
providing higher physiological relevance especially 
when applied to study processes highly dependent on the 
chemical environment, whereas a disadvantage lies in 
the non-specific isotopic enrichment during protein 
expression, which causes cellular background signals to 
be detected together with the protein of interest, 
requiring further data processing.  
Despite the general limitation of in-cell solution 
NMR, which cannot detect globular proteins if they 
interact with large cellular components (see 
Troubleshooting of Step 33), this protocol should be 
applicable to a broad range of soluble cytoplasmic 
proteins, and can be adapted to proteins localized in 
different cellular compartments.  
Applications 
The protocol for protein overexpression in human 
HEK293T cells for in-cell NMR studies has been 
successfully applied to a number of systems5,22–27. 
Several functional processes, including metal uptake5,24, 
disulfide bond formation5,22,24,26, protein folding22,26, 
have been characterized for different proteins with 
different features and behaviours, and in different 
cellular compartments23. For superoxide dismutase 1 
(SOD1) and for a number of its familial Amyotrophic 
Lateral Sclerosis (fALS)-linked mutants, the post-
translational modifications occurring after the protein 
synthesis were studied by analyzing the protein state as 
a function of the growth conditions5,24. The maturation 
process of SOD1 involves zinc binding, homodimer 
formation, copper uptake and oxidation of the 
intrasubunit disulfide bond. By treating the cells 
differently during protein expression, the various protein 
conformations were observed, from the immature, 
metal-free form to the various metallated and/or 
oxidized forms to the final mature protein5.  
In cells grown without supplements of metal ions, 
essentially only the monomeric, metal-free, reduced 
SOD1 (apo-SOD1) is present. Addition of Zn2+ to the 
culture medium eliminated the apo-SOD1 species and 
only the dimeric species with one Zn2+ ion bound to each 
subunit (E,Zn-SOD1) is formed. Therefore, Zn2+ ions 
are efficiently taken up by cells in culture and bind 
specifically to the native binding site of dimeric SOD1 
in stoichiometric amounts. Copper incorporation of 
SOD1 in eukaryotes is known to be dependent on the 
CCS protein. When both proteins are overexpressed, the 
SOD1 intrasubunit disulfide bond is partially oxidized. 
When cells, after overexpression of both SOD1 and 
CCS, are incubated with Cu(II), almost all SOD1 is in 
the Cu(I),Zn-bound form, at variance with cell samples 
with basal CCS level. Moreover, the intrasubunit 
disulfide bridge of SOD1 is completely oxidized. This 
behaviour indicates that in vivo CCS has a role in 
promoting both copper incorporation in SOD1 and 
disulfide bond formation28.  
SOD1 maturation pathway has also been 
investigated for a series of fALS-linked SOD1 mutants 
revealing that, for a subset of mutants, impaired zinc 
binding triggers the accumulation of an unstructured 
species in the cytoplasm24. Co-expression of CCS 
prevented SOD1 misfolding, and restored the correct 
maturation pathway. This application highlights the 
advantage of intracellular protein expression over the 
protein delivery approaches. In the apo state, these 
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SOD1 mutants are intrinsically destabilized, are prone 
to misfolding and aggregation in vitro, and cannot reach 
the high concentration needed for efficient intracellular 
delivery. Therefore, the approach described here is 
especially valuable for studying protein misfolding 
events which are difficult to control in vitro. 
We have also characterized the folding and redox 
properties of Mia40, an oxidoreductase involved in the 
mitochondrial protein import process22. The in-cell 
NMR spectra revealed that Mia40 in the cytoplasm is 
present mostly in a folded state, which is not competent 
for mitochondrial import. The dependence of Mia40 
redox and folding state on the overexpression of 
Glutaredoxin1 (Grx1) and Thioredoxin1 (Trx1) has also 
been investigated22. The amount of intracellular folded 
Mia40 decreased when either Grx1 or Trx1 were co-
expressed, showing that both thiol-disulfide regulating 
proteins affect the Mia40 redox state. Grx1 keeps Mia40 
reduced more effectively than Trx1, suggesting that the 
two proteins differentially regulate the mitochondrial 
import of Mia40.  
Experimental design 
While this protocol was optimized on HEK293T 
cells, in principle protein expression at sufficient levels 
can be obtained in other mammalian cell lines. 
However, some steps will likely have to be modified. 
Specifically, the transfection method and the choice of 
the promoter for constitutive gene expression should be 
optimized for each cell line. As a rule of thumb, cells 
that have been used successfully as protein expression 
systems (e.g. HEK293T29 cells, Chinese Hamster Ovary 
(CHO)30 cells and simian-derived COS cells31) should 
be able to reach high transfection efficiency and 
sufficient protein levels for in-cell NMR experiments. 
The genes of interest need to be cloned in a vector 
suitable for high level constitutive protein expression in 
mammalian cells. In this protocol, the pHLsec plasmid 
is used29,32. The gene of interest is transcribed by a CAG 
promoter, which is very active in HEK293T cells and 
allows high protein levels to be reached. The pHLsec 
vector is designed for expressing secreted proteins, 
however the secretion sequence can be removed during 
the cloning, allowing the native proteins to be expressed 
in the cytoplasm5. In order to ensure successful 
transfection and protein expression, the transfected 
DNA has to be endotoxin-free, as bacterial endotoxins 
induce inflammatory reactions of the mammalian 
immune system. Usually, endotoxin-free Midi and Maxi 
DNA preparations are preferred, as they provide enough 
DNA for ~15 and ~30 in-cell NMR samples, 
respectively. The DNA is transfected as a complex with 
the cationic polymer polyethylenimine (PEI), which 
ensures high transfection efficiency and high copy 
number per cell29.  
For each protein, the optimal expression conditions 
(in terms of time and amount of DNA) may have to be 
screened, either by Coomassie-stained SDS-PAGE or by 
Western Blotting of the cell lysates. Usually, the highest 
expression levels are reached between 48 and 72 hours 
after transfection. It is possible to co-express two 
proteins simultaneously by mixing the two DNAs in the 
transfection procedure. Optimal co-expression 
conditions have to be screened by varying the amount of 
DNA of each construct. If desired, the protein 
expression level can be decreased by diluting the DNA 
encoding the protein of interest with an empty DNA 
vector (the total amount of DNA is kept constant). The 
screening can be done on scaled-down cultures (e.g. in 
T25 flasks or 6-well dishes). To quantify the expression 
levels, the lysates obtained for each condition are run on 
a reducing SDS-PAGE together with serial dilutions of 
a purified protein sample at known concentration, which 
provides a calibration curve. Each sample should be 
loaded at different dilutions for better quantification. 
Protein detection can be performed by densitometry 
analysis on the Coomassie-stained gel. Alternatively, 
especially for lower expression levels, the proteins can 
be detected by Western Blotting and densitometry 
analysis.  
Some applications may require additional reagents to 
be added to the cell culture at some point of the sample 
preparation. As an example, some proteins need 
cofactors to fold properly and/or to reach the functional 
state. Such cofactors can be either small molecules or 
metal ions. In order to avoid cellular toxicity or 
decreased protein expression, the optimal concentration 
of cofactor(s) and timing of the addition(s) should be 
tested. For example, copper ions are toxic at high 
concentration and inhibit protein expression, so they 
have to be added at a later stage following protein 
expression. Other transition metals, such as zinc, do not 
seem to affect protein expression and can be added at the 
time of transfection. Protein expression and cell viability 
can be checked by Western Blot and Trypan Blue 
staining, respectively, while the effects on the protein 
folding/functional state can be observed by NMR 
experiments on intact cells or lysates. 
A prerequisite to perform heteronuclear NMR 
experiments is that NMR-active isotopes (13C and 15N) 
must be incorporated into the overexpressed proteins. 
For this purpose, the growth medium needs to be 
replaced at the time of transfection with a medium 
isotopically labeled. Labeled media suitable for 
mammalian cell growth are commercially available 
(Bioexpress 6000, CIL), and cost around 5,500 USD/l 
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(U-15N) and 11,000 USD/l (U-13C,15N). Despite the high 
initial costs, following our protocol only 20 ml of 
labeled medium are required to obtain one in-cell NMR 
sample, resulting in 110 USD/sample (15N) and 220 
USD/sample (13C,15N). In most cases, the labeled media 
can be recovered after protein expression, centrifuged to 
remove cell debris and residual DNA:PEI complex, and 
used again to prepare a second cell sample, further 
reducing the cost per sample. For some applications, 
typically when some protein signals fall in a spectral 
region free from cellular background (for example, 
histidine ring N-1H protons5,24; isolated 1H signals 
arising from the protein hydrophobic core22,27), 
unlabeled samples can be prepared for 1H-only in-cell 
NMR experiments, resulting in the cost per sample 
being greatly reduced. Amino acid-selective labeling 
schemes can also be used, by preparing a home-made 
cell growth medium following the composition of the 
commercial unlabeled medium and adding the 
isotopically labeled amino acid(s) according to the 
desired labeling scheme. During protein expression, the 
amount of serum is lowered to 2%, to prevent excessive 
isotopic dilution and to minimize non-specific isotopic 
incorporation, by decreasing the cell growth rate32,33.  
In our protocol, 3 mm Shigemi NMR tubes are used 
to minimize the amount of cells needed and cut the 
sample preparation costs. On average, an NMR sample 
obtained from one confluent T75 flask (75 cm2) contains 
3.5×107 ± 1.1×107 cells, which occupy 130 ± 30 µl when 
spun down; this is enough to fill the tube section 
corresponding to the active volume of the NMR 
instrument. The resulting pellet contains ~50% (v/v) 
cells (average cell volume of 2 pl). 3 mm Shigemi tubes 
can be used in 5 mm probes with a proper 
spinner/adapter. If more cells are available, larger tubes 
(5 mm normal/Shigemi tubes) may be used to increase 
the signal to noise ratio (S/N) of the experiments, as 
shown elsewhere34,35.  
After the cells are detached from the culture flask, 
the in-cell NMR experiments should be performed as 
quickly as possible to minimize cell death. In order to 
overcome the intrinsic low sensitivity of NMR, some 
pulse sequences have been optimally designed to 
maximize the S/N ratio per unit time. For example, 1H-
15N SOFAST-HMQC experiments are preferred instead 
of the classical HSQC variants. Usually, more than 90% 
of HEK293T cells are still viable after 2-2.5 hours at 
37°C, which is longer than needed to collect one 
SOFAST-HMQC spectrum (1 h) plus several 1D 1H 
NMR spectra. Longer experimental times result in cell 
death due to O2 and/or nutrients depletion, and build-up 
of acidic metabolic products. For these reasons, NMR 
experiments should be planned and set up in advance 
whenever possible.
 
 
MATERIALS 
REAGENTS 
• HEK293T cell line (ATCC CRL-3216) !CAUTION 
the cell lines used should be regularly checked to 
ensure they are authentic and are not infected with 
mycoplasma. 
• pHLsec plasmid29 containing the gene of interest; 
empty pHLsec plasmid. 
• Phosphate-Buffered Saline (PBS, Life Technologies, 
cat. no. 10010) 
• Dulbecco's Modified Eagle Medium, high glucose 
(DMEM, Life Technologies, cat. no.10313-021) 
• Fetal Bovine Serum (FBS, Life Technologies, cat. no. 
10270) 
• L-Glutamine (Life Technologies, cat. no. 25030) 
• Penicillin-Streptomycin (10,000 U/ml) (Life 
Technologies, cat. no. 15140-122) 
• Trypsin-EDTA (0.05%)  (Life Technologies, cat. no. 
25300-054) 
• MEM Non-Essential Amino Acids Solution (100X) 
(NEAA, Life Technologies, cat. no. 11140-035) 
• Polyethylenimine (PEI), branched, avg. Mw 25 kDa 
(Sigma-Aldrich, cat. no. 408727) 
• BioExpress 6000 (U-15N, 98%) (CIL, cat. no. CGM-
6000-N) 
• HEPES (Sigma-Aldrich, cat. no. H4034) 
• D-(+)-Glucose (Sigma-Aldrich, cat. no. G8270) 
• D2O (Sigma-Aldrich, cat. no. 453366) 
• Ethylenediaminetetraacetic acid disodium salt 
solution (EDTA, Sigma-Aldrich, cat. no. E7889) 
• 4-(2-Aminoethyl)benzenesulfonyl fluoride 
hydrochloride (AEBSF Hydrochloride protease 
inhibitor, PanReac AppliChem, cat. no. A1421,0001) 
• Trypan Blue Solution (0.4%) (Sigma-Aldrich, cat. no. 
T8154) !CAUTION Hazard statement(s): H350, may 
cause cancer. 
Optional reagents: 
• L-Methionine (Methyl-13C, 99%) (CIL, cat. no. 
CLM-206-PK) 
• L-Cysteine (U-13C3, 97-99%; 15N, 97-99%) (CIL, 
cat. no. CNLM-3871-0.1) 
• CaCl22H2O (Merck Millipore, cat. no. 1.02382) 
• Fe(NO3)39H2O (Sigma-Aldrich, cat. no. 216828) 
• MgSO47H2O (Sigma-Aldrich, cat. no. M2643) 
• KCl (Merck Millipore, cat. no. 1.04936) 
• NaHCO3 (Carlo Erba, cat. no. 478537) 
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• NaCl (Sigma-Aldrich, cat. no. 31434) 
• NaH2PO4 (Merck Millipore, cat. no. 1.06346) 
• L-ArginineHCl (Sigma-Aldrich, cat. no. A5006) 
• L-Cysteine2HCl (Sigma-Aldrich, cat. no. C7352) 
• Glycine (Sigma-Aldrich, cat. no. G7126) 
• L-HistidineHClH2O (PanReac AppliChem, cat. no. 
A1591) 
• L-Isoleucine (Sigma-Aldrich, cat. no. I7403) 
• L-Leucine (Sigma-Aldrich, cat. no. L8000) 
• L-LysineHCl (Sigma-Aldrich, cat. no. L5626) 
• L-Methionine (Sigma-Aldrich, cat. no. 64320) 
• L-Phenylalanine (Sigma-Aldrich, cat. no. P5482) 
• L-Serine (Sigma-Aldrich, cat. no. 84959) 
• L-Threonine (Sigma-Aldrich, cat. no. T8625) 
• L-Tryptophane (Sigma-Aldrich, cat. no. 93660) 
• L-Tyrosine2Na2H2O (Sigma-Aldrich, cat. no. 
93830) 
• L-Valine (Sigma-Aldrich, cat. no. 94620) 
• Choline Chloride (Sigma-Aldrich, cat. no. C7527) 
• Folic Acid (Sigma-Aldrich, cat. no. F7876) 
• D-Pantothenic Acid½Ca (Sigma-Aldrich, cat. no. 
25,972-1) 
• PyridoxineHCl (Sigma-Aldrich, cat. no. P5669) 
• Niacinamide (Sigma-Aldrich, cat. no. N-3376) 
• myo-Inositol (Sigma-Aldrich, cat. no. I7508) 
• Riboflavin (Sigma-Aldrich, cat. no. R-4500) 
• ThiamineHCl (Merck Millipore, cat. no. 1.08181) 
• Purified proteins, either unlabeled or labeled 
according to the in-cell NMR experiments (i.e. U-15N 
or amino acid-specific)  
EQUIPMENT 
• All the equipment necessary for maintaining cultured 
mammalian cells.  
• All the equipment to perform SDS-PAGE and 
Western-Blotting procedures. 
• Access to a high-field NMR spectrometer equipped 
with a cryogenically cooled probe-head is a 
requirement for successful in-cell NMR analysis. The 
data shown here were obtained at a 950 MHz Bruker 
Avance spectrometer equipped with a 5 mm TCI 
CryoProbe.  
• NMR data-processing software (e.g. TOPSPIN for 
Bruker machines). 
• Visualization and analysis software for NMR spectra 
(e.g. TOPSPIN, CARA, SPARKY and others). 
• Cell culture flasks, T75 (Greiner Bio-one, cat. no. 
658175). 
• Burker chamber (Sigma-Aldrich, cat. no. BR718920 ). 
• 3 mm Shigemi NMR tubes (Cortecnet, cat. no. BMS-
003). 
• Liquid N2. 
REAGENT SETUP 
Complete DMEM Add 1x L-Glutamine, 1x Penicillin-
Streptomycin and 10% FBS to DMEM. Can be stored at 
4°C for 1 month. 
Unlabeled expression medium Add 1x L-Glutamine, 
1x Penicillin-Streptomycin, 1x NEAA and 2% FBS to 
DMEM. Can be stored at 4°C for 1 month. 
Labeled expression medium Add 1x Penicillin-
Streptomycin and 2% FBS to BioExpress 6000. Freshly 
prepare the amount needed for each experiment. 
"Home-made" DMEM Weigh every component 
following the recipe of the commercial DMEM (e.g. 
Sigma-Aldrich, Life Technologies) and dissolve them in 
H2O. Adjust the pH of the solution to 7.5. Sterilize the 
medium by filtration (0.22 µm). The medium can be 
stored at -20°C for 1 year. For the expression, add 1x 
Penicillin-Streptomycin, 2% FBS to DMEM and the 
labeled amino acid following the recipe. Add 1x L-
Glutamine and 1x NEAA only if they do not contain the 
amino acid chosen for labeling. Freshly prepare the 
amount needed for each experiment. 
 
PROCEDURE 
Splitting of confluent cells (day 1) ● TIMING 30 min 
1| Remove the medium from a confluent T75 flask of HEK293T cells (containing ~1-3 x 10^7 cells). One T75 flask is 
sufficient to inoculate 4-10 flasks for in-cell NMR experiments (see Step 7). 
2| Wash the cells twice with 7 ml of PBS. 
3| Add 2 ml of trypsin/EDTA, incubate 2 min at room temperature to detach the cells. 
4| Inactivate trypsin with 20 ml of complete DMEM. 
5| Centrifuge cells at 800 g for 5 minutes at room temperature, discard the supernatant. 
6| Resuspend the cell pellet in 10 ml of complete DMEM, carefully breaking up any clumps of cells. 
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7| If transfecting the cells on day 2, for each in-cell NMR sample inoculate 2.2 ml of cell suspension in a new T75 
flask, and add 20 ml of complete DMEM. Alternatively, the DNA transfection can be performed on day 3. If that is 
the case, inoculate 1 ml of cell suspension per in-cell NMR sample. See Figure 1 for the alternative timing. 
8| Place the inoculated flasks at 37°C in a humidified atmosphere containing 5% CO2. 
Transient transfection with the gene(s) of interest / with the empty vector (day 2) ● TIMING 30 min 
9| To 2.5 ml of medium (depending on the chosen labeling scheme, use either DMEM, 15N-labeled medium or home-
made medium with specific labeled amino acids) without serum add 25 µg of endotoxin-free DNA.  
10| To 2.5 ml of medium without serum (the same as in Step 9) add 50 µg of PEI. 
11| Slowly add the PEI solution to the DNA solution. 
▲CRITICAL STEP To ensure proper transfection efficiency, add PEI to DNA, not vice versa. Do not shake the tube.  
12| Wait for 20 minutes in order to allow the formation of the DNA-PEI complex.  
13| Discard the old medium from the T75 flask and carefully eliminate any trace of medium 
14| Add the DNA-PEI mixture to the cells and subsequently add 15 ml of the same medium as in Step 9 supplemented 
with 2% FBS and antibiotics. Non-toxic cofactors / metal ions can be added to the expression medium during this 
step. If toxic compounds / metal ions are required, they should be added after protein expression, prior to cell 
collection. 
15| Place the flask at 37°C in a humidified atmosphere containing 5% CO2. Carry on protein expression for 2 or 3 days 
(see Figure 1). 
Setup of the NMR experiments (day 4) ● TIMING 1 h 
16| Set the experimental temperature at the NMR spectrometer. Typically, the temperature is set to 310 K, which is 
close to the physiological temperature, and provides 2-3 hours of sample stability. Lower temperatures may increase 
the sample stability, but they usually cause noticeable line broadening, due to the increased viscosity of the 
environment.  
17| Prepare an empty dataset at the NMR spectrometer and set the parameters for each NMR experiment by following 
the options A and B. This step should be performed at any time prior to the preparation of the in-cell NMR sample, 
in order to minimize the delay between cell collection and data acquisition. 
There are several variants of NMR experiments which are suitable for short-lived samples such as living HEK293T 
cells put in an NMR tube. Here we describe those most commonly used in the reported applications of this protocol. 
Typically, samples are first analyzed with a 1D 1H NMR experiment with excitation sculpting for water suppression 
(Bruker zgesgp pulse program)36(option A). In the case that a sizable number of 1H resonances of the protein of interest 
fall in regions of the 1H spectrum free of signals from the cellular background (i.e. >10 ppm or <0.5 ppm), analysis 
by 1H NMR on simply unlabeled cell samples can be performed. In such cases, a 1D 1H NMR WATERGATE 
experiment with a 3-9-19 binomial pulse train for water suppression provides good sensitivity (Bruker p3919gp pulse 
program)37.  
With 15N labeled samples, after the acquisition of a 1D 1H NMR spectrum, a 1H-15N SOFAST-HMQC NMR 
experiment (Bruker sfhmqcf3gpph pulse program)38 is acquired (option B), which will be the major source of 
structural information. The SOFAST-HMQC sequence relies on band-selective shaped pulses for 1H excitation and 
refocusing. Both the pulse length and the offset frequency can be adjusted depending on the desired 1H excitation 
region. In our standard setup, the pulse lengths and offset are calculated for the amide region of folded proteins. The 
inter-scan delay can be optimized, within the safe operating limits of the instrument, by measuring the obtained S/N 
per unit time at different delays. Optionally, non-uniform sampling schemes can be used, either to reduce the 
acquisition time for each experiment (provided the S/N is high enough) or to improve the resolution along the 15N 
dimension (within the limits of 15N transverse relaxation)3. 
(A) Parameters for 1D 1H NMR experiments 
(i) Center the 1H carrier frequency on the water signal at ~4.7 ppm 
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(ii) For the zgesgp pulse program, set the spectral width to 20 ppm and a 1000 µs 180° square pulse for water 
suppression. Set an inter-scan delay of ≥ 1 second. Acquire the spectrum with 128 scans. 
(iii) For the p3919gp pulse program, set the spectral width to ≥ 25 ppm, and adjust the delay for binomial water 
suppression so that the maximum excitation is centred at the chemical shifts of the signals of interest. Set an inter-
scan delay of ≥ 1 second. Acquire with ≥ 512 scans. 
(B) Parameters for 2D 1H-15N SOFAST-HMQC experiments 
(i) Center the 1H carrier frequency on the water signal at ~4.7 ppm and the 15N frequency at ~118 ppm. 
(ii) Set the spectral width to 15 ppm for 1H and 50 ppm for 15N, 2048 points and 128 increments (acquisition times of 
67.4 ms and 13.3 ms at 950 MHz, respectively). 
(iii) Center the band-selective 1H shaped pulses (use a PC9 shape for excitation and a Reburp shape for refocusing) at 
8.5 ppm or higher, to avoid excitation of the water resonance.  
(iv) Calculate the power level for the PC9 shaped pulse (either 90° or 120° Ernst angle can be used). Set the duration to 
1620 µs (at 950 MHz). 
(v) Calculate the power level for the Reburp shaped pulse, set the duration to 896 µs (at 950 MHz). At different magnetic 
fields, both pulse lengths need to be adjusted with the following formula: pnew = pold × (Bold/Bnew). 
(vi) Set an inter-scan delay of 300 ms. Acquire with 64 scans per increment. 
Preparation of the NMR sample ● TIMING 1 h 
18| Remove the old medium from the T75 flask. 
? TROUBLESHOOTING 
19| Wash the cells twice with 7 ml (each) of PBS. 
20| Detach the cells with 2 ml of trypsin/EDTA, incubate 5 min at room temperature to detach the cells. 
▲CRITICAL STEP trypsin may take slightly longer to detach transfected cells. If necessary, incubate the cells at 37°C. 
21| Inactivate trypsin with 20 ml of complete DMEM. 
22| Centrifuge the cells at 800 g for 5 minutes at room temperature, discard the supernatant. 
23| Wash cells with 10 ml of PBS to remove the residual medium. 
24| Centrifuge the cells at 800 g for 5 minutes at room temperature, discard the supernatant. 
25| Transfer the cells to a 1.5 ml capped tube. 
26| Resuspend the cell pellet in 180 µl of NMR buffer (DMEM supplemented with 70 mM HEPES, 90 mM Glucose, 
20% (v/v) D2O). This formulation was optimized for increased buffering capacity and for compensating for the 
faster glucose consumption, due to the high cell density in the NMR tube.  
▲CRITICAL STEP DMEM is buffered by CO2/HCO3−. To avoid the formation of CO2 bubbles in the NMR tube, after 
HEPES addition, remove the CO2 by bubbling air for 10 minutes. 
27| Take 10 µl of the cell suspension for measuring the cell viability before the NMR experiments by Trypan Blue 
staining (Steps 45-48). The aliquot can be stored on ice for 1-2 hours. 
28| With a long glass pipette, transfer the cell suspension to the bottom of a 3 mm Shigemi NMR tube; do not use the 
inner plunger, close the tube with a standard 3 mm cap. 
29| Allow the cells to settle at the bottom of the tube. This step can be made quicker by slowly spinning the tube with a 
hand-operated centrifuge for ~3 minutes. Do not remove the supernatant. 
Acquisition of the NMR spectra ● TIMING 1-3 h 
30| Load a data set with the desired NMR experiments (see Step 17) 
31| Insert the in-cell NMR sample into the magnet, check the tuning of the probe head and shim the magnet.  
▲CRITICAL STEP In our experience, the automated shimming procedure of modern Bruker instruments (the ‘topshim’ 
routine) applied on the cell samples yields results as good as on the same Shigemi tube filled with aqueous buffer and the 
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inner plunger. In practice, any residual field inhomogeneity seems not to be critical compared to the signal broadening 
caused by the protein of interest being inside the cells. Water suppression could pose some issues on poorly shimmed 
samples. However, SOFAST-HMQC spectra can be optimized for such samples by moving the 1H excitation window 
(i.e. the offset frequency of the band-selective 1H shaped pulses) further away from the water signal. 
32| Calibrate the 1H 90° hard pulse length. 
33| Adjust the 1H power levels in each pulse sequence according to the 1H hard pulse. 
34| Acquire the NMR spectra.  Process the data as described in Box 1. A quick processing can be performed to check 
the outcome of the experiment, while the background subtraction can be performed at a later stage.  
? TROUBLESHOOTING 
Recovery of the cell sample ● TIMING 10 min 
35| After the NMR experiment, resuspend the cells in the supernatant inside the NMR tube with a glass pipette and 
transfer the suspension in a 1.5 ml capped tube. 
36| Take 10 µl of the cell suspension for measuring the cell viability after the NMR experiments by Trypan Blue staining 
(Steps 45-48). The aliquot can be stored on ice for 1-2 hours. 
37| Centrifuge the cells at 800 g for 5 minutes at room temperature. 
38| Collect the supernatant, to be analyzed with NMR for protein leakage by performing Steps 30-35. 
? TROUBLESHOOTING 
■ PAUSE POINT the cell pellet and the supernatant can be stored at –20°C before preparation of the cell lysate. 
Preparation of the cell lysate ● TIMING 1.5 h 
39| Resuspend the cell pellet in 150 µl of PBS buffer + 0.5 mM EDTA + AEBSF. 
40| Lyse the cells by applying 8-10 freeze–thaw cycles alternating between liquid N2 and warm water. 
41| Centrifuge the lysate at 16000 g for 1 hour, 4 °C and collect the supernatant. 
42| Analyse the cleared cell lysate by NMR by performing Steps 30-35. A conventional 3 mm NMR tube can be used.  
? TROUBLESHOOTING 
43| (optional) Perform further analysis on lysate or on supernatant, e.g. by SDS-PAGE or Western Blot. 
Trypan Blue test ● TIMING 10 min 
▲CRITICAL Perform the Trypan Blue test on the cell aliquots taken before and after the NMR experiments (Steps 27 
and 37):  
44| Dilute the 10 µl cellular suspension in 500 µL of DMEM without serum. 
45| Add 100 µl of Trypan Blue Stain. 
46| Wait for 5 minutes. 
▲CRITICAL STEP Do not exceed 5 minutes, otherwise every cell becomes stained. 
47| Put 10 µl in a Burker chamber and count the number of blue (B) and white (W) cells. Calculate the cell viability as 
W/(B+W). Ideally, cell viability should remain higher than 90% after the NMR experiments. 
In vitro NMR data collection 
48| (optional) Acquire the same set of NMR experiments on purified protein samples by performing Steps 30-35, in 
order to compare the in-cell and in vitro NMR data.  
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Box 1 | Processing of the 2D NMR experiments 
Typically, 2D 1H-15N NMR spectra are processed by multiplying both dimensions by a square sine bell function (90° 
shift), zero-filled and Fourier transformed in both dimensions. In some cases, amide resonances arising from the in-cell 
NMR sample will relax faster than the acquisition time (in one or both spectral dimensions). In such cases, the spectra 
can be improved by decreasing the number of effective data points used in the Fourier transform, prior to zero-filling. As 
this choice can be made during the processing step, it is suggested to always acquire the NMR spectra with the highest 
possible number of points in both dimensions (compatibly with the experimental time and with the safety limits for 
decoupling during acquisition), in order to maximize the spectral resolution for slow-relaxing signals. If needed, some 
points can then be discarded later. 
In the case of isotopically labeled cell samples, during protein expression the NMR-active isotope(s) will also be 
incorporated into all the other molecules of the cells. Therefore, 15N-labeled cell samples give rise to background amide 
signals in the 2D NMR spectra, originating mostly from other proteins and abundant peptides, such as glutathione. These 
background signals can be greatly reduced in the 2D NMR spectra by subtracting two Fourier-transformed spectra, one 
acquired on the in-cell NMR sample containing the protein(s) of interest, the other acquired on a control in-cell NMR 
sample, prepared exactly in the same conditions as the previous but transfecting the cells with the empty DNA vector 
(Fig. 2). The two experiments need to be set up and processed using identical parameters (except for the power levels of 
the shaped pulses, which should be adjusted according to the 1H hard pulse length). Therefore, it is advisable to plan the 
set of 2D NMR experiments always combined with a control in-cell NMR spectrum. All these spectra should be collected 
with identical experimental parameters such as temperature, spectral width, number of increments and shape pulse 
profiles. Thus, a single control in-cell NMR sample can be used for processing different in-cell NMR experiments, 
provided that the cell culture conditions and experimental set up have not changed along the collection of the various 
experiments. 
 
? TROUBLESHOOTING 
 
Step 18: 
Problem: Most cells are detached from the flask and are floating in the medium. 
Possible solutions: Cytotoxic effects may arise from added cofactors. Determine the optimal conditions by lowering the 
cofactor concentration.  
The expressed protein may be toxic. Tune the amount of transfected DNA by diluting the plasmid containing the gene 
with an empty vector. 
 
Step 35: 
Problem: No signals of the protein of interest are observed in the in-cell NMR spectra. 
Possible solution: Soluble, globular proteins are sometimes not detectable by in-cell solution NMR due to interactions 
with other cellular components, which slow down the average tumbling rate. For example the human proteins Grx1, Trx1 
and profilin 1 do not give rise to detectable signals in the NMR spectra (Supplementary Fig. 1)22,25. To determine whether 
this is the case, lyse the cells and acquire the same NMR spectra on the cleared cell lysate. If the protein is clearly detected 
in the cell lysate, but not in the cells, a likely reason is the occurrence of transient interactions with large intracellular 
molecules. In such cases, a mutational strategy may be followed, to selectively disrupt transient interactions. This 
approach has proven to be successful in making human profilin 1 detectable by in-cell solution NMR25. 
 
Step 39: 
Problem: The protein NMR signals are detected in the supernatant: the protein has leaked from the cells. This is likely a 
consequence of high cell mortality, which can be assessed with the Trypan Blue test. 
Possible solutions: Try to be as quick as possible in the preparation of the NMR sample by reducing the dead-times in the 
procedure.  
Reduce the acquisition time of the NMR experiments. 
The over-expressed protein might be produced at levels that are toxic to the cells. Tune the amount of transfected DNA 
by diluting the plasmid containing the gene with an empty vector; this will decrease the number of copies of the plasmid 
entering each cell.  
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Step 43: 
Problem: No signals of the protein of interest are observed in the NMR spectra of the cleared cell lysate. 
Possible solution: the protein of interest is not expressed to sufficient levels. Check the presence of the protein with SDS-
PAGE or Western Blotting. Vary the amount of DNA in the transfection procedure.  
● TIMING  
Steps 1–8, splitting of confluent cells: 30 min 
Steps 9–15, transient transfection with the gene(s) of interest or empty vector: 30 min 
Steps 16 and 17, setup of the NMR experiments: 1 h 
Steps 18–29, preparation of the NMR sample: 1 h 
Steps 30–34, acquisition of the NMR spectra: 1–3 h 
Steps 35–38, recovery of the cell sample: 10 min 
Steps 39–43, preparation of the cell lysate: 1.5 h 
Steps 44–48, Trypan Blue test: 10 min 
Box 1, processing of the 2D NMR experiments: 30 min 
ANTICIPATED RESULTS 
The described protocol allows overexpression of isotopically labeled proteins in human HEK293T cells and enables the 
acquisition of heteronuclear NMR experiments on living cells and cell lysates. 
A number of proteins among those we tested reached expression levels suitable to be observed by in-cell NMR: SOD1 
(both WT and fALS-related mutants), CCS, HAH1, Mia40, Cox17, profilin1 (with surface mutations), Grx1, Trx1 (Fig. 
3a). The highest expression levels obtainable vary among proteins, ranging from ~150 µM (for SOD1) to ~10 µM (for 
Cox17), as measured from either Coomassie-stained SDS-PAGE or western blot (Fig. 3b,c and Supplementary Fig. 2). 
The expression levels can be lowered by decreasing the amount of DNA added in the transfection step, making possible 
to approach physiological concentrations, when the latter are compatible with NMR detectability (Fig. 3d). The 
expression levels obtained in each condition are very reproducible, falling within a 5% (s.d.) from the average calculated 
over several samples which were identically prepared in different years. Most of the proteins reported here can be clearly 
detected in the in-cell 1H-15N SOFAST-HMQC NMR spectra recorded on uniformly 15N-labeled cell samples (Fig. 4a-
f). These 1H-15N in-cell NMR spectra contain residue-level information of the protein conformational properties, and can 
be compared with the spectra acquired on the same proteins in vitro (Fig. 4g-l) to better characterize the intracellular 
species. Following this approach, different metallation states of SOD1 are easily identified: apo-SOD1, which is a partially 
disordered monomer (Fig. 5a, magenta), is readily converted to E,Zn-SOD1 (a well folded homodimer) when cells are 
treated with zinc (Fig. 5a, black).  
Amino acid-selective labeling can be obtained by using home-made expression media supplemented with the desired 
labeled amino acid(s). For example, spectra can be obtained for samples grown with either [15N]cysteine (Fig. 5b) or 
[13C-methyl]methionine (Fig. 5c). The labeling efficiency when using [15N]cysteine homemade media was estimated from 
crosspeak intensities as 75% ± 10% (s.d., calculated on 4 cysteine signals) of the efficiency obtained in the commercial 
[U-15N] medium, while the intensity of the background signals was much lower (compare Fig. 2a and 5b). Other amino 
acid-selective labeling schemes can be achieved in principle, however the amount of spurious isotopic incorporation is 
expected to vary with the nature of the amino acid. The [15N]cysteine labeling is especially useful to investigate the redox 
state of the protein of interest, whenever the formation of disulfide bonds affects the amide chemical shifts of the involved 
cysteines. Indeed, the 1H-15N SOFAST-HMQC spectra acquired on HEK293T cells expressing [15N]cysteine-labeled 
SOD1 showed that Cys146, which forms an intrasubunit disulfide bond with Cys57 in the mature enzyme, was reduced 
(Fig. 5b). The methionine labeling has the advantage of being relatively inexpensive, and allows the investigation of 
slow-tumbling macromolecules due to the favorably slower relaxation of the CH3 moiety39 (Fig. 5c). 
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Figures 
 
 
Figure 1 | Alternative timings for transfection and protein expression. Different timings of cell transfection and protein expression can 
be planned to fit the experimental needs and the NMR instrument schedule. Transfection can be performed either at day 2 or day 3 
after seeding the cells at day 1. For transfection at day 2, seed 2.2 ml out of 10 ml of cell suspension (from a confluent T75 flask); for 
transfection at day 3, seed 1 ml out of 10 ml of cell suspension. The NMR sample will be prepared on different days, according to the 
planned protein expression time. 
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Figure 2 | Subtraction of 2D 1H-15N SOFAST-HMQC in-cell NMR spectra to eliminate the background signals. (a) NMR spectrum of 
cells expressing SOD1 in U-15N-labeled medium. The amide signals of zinc-bound SOD1 are detected together with background signals 
(centred around 8.3 ppm) arising from other 15N-labeled molecules. (b) NMR spectrum of a control cell sample transfected with an 
empty DNA vector. Only the background signals are detected. (c) NMR spectrum obtained by subtracting the background spectrum 
(b) to the original spectrum (a). Additional signals arising from SOD1 are now clearly identified in the central region. 
 
 
Figure 3 | Expression levels of different proteins transiently transfected in HEK293T cells. (a) SDS-PAGE analysis of cleared cell 
lysates obtained from cells overexpressing different proteins for 48 h. (b) Western Blot analysis of cleared cell lysates from cells 
transfected with empty vector (control) and Cox17 cDNA (transfected), loaded at different dilutions (vol/vol) and stained with anti-
hCox17 antibody. (c) Quantification of overexpressed profilin1 by SDS-PAGE. Purified histidine-tagged profilin1 is used as a reference 
sample; both samples are loaded at different dilutions (vol/vol). (d) Dependence of the expression levels of Mia40 on the dilution of 
the corresponding DNA in the transfection mixture. Each cell lysate is loaded in the same amount in each lane. See also Supplementary 
Fig. 2. 
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Figure 4 | 1H-15N in-cell NMR spectra (black) and the corresponding in vitro NMR spectra (red). (a-f) Background-subtracted 1H-15N 
SOFAST-HMQC in-cell NMR spectra recorded on cells expressing uniformly 15N-labeled proteins. (a) SOD1; (b) CCS (only the C-
terminal unfolded domain is detected); (c) HAH1; (d) Mia40; (e) Cox17; (f) profilin1 (with surface mutations). (g-l) 1H-15N NMR 
spectra recorded on purified 15N-labeled samples of the same proteins as in (a-f). The spectrum of purified CCS (h) is a 1H-15N HSQC-
TROSY, in which crosspeaks arising from the folded domains of CCS are also visible at lower intensity.  
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Figure 5 | (a) Overlay of 1H-15N SOFAST-HMQC in-cell NMR spectra recorded on cells expressing SOD1 without supplemented zinc 
(apo-SOD1, magenta) and in excess of zinc (E,Zn-SOD1, black). (b,c) 2D heteronuclear in-cell NMR spectra recorded on cells 
expressing selectively labeled proteins. (b) 1H-15N SOFAST-HMQC in-cell NMR spectrum of [15N]cysteine-labeled SOD1. SOD1 
cysteine crosspeaks are labeled. For the Cys146 crosspeak, the oxidation state is also indicated. (c) 1H-13C HSQC in-cell NMR spectrum 
of [methyl-13C]methionine-labeled mutant profilin1. The methionine crosspeaks arising from the protein are indicated. Signals arising 
from cellular background are indicated with an asterisk.  
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Supplementary Figures 
 
 
Supplementary Figure 1 | Grx1 is not detected in the in-cell NMR spectra. 1H-15N SOFAST-HMQC NMR spectra of (a) cells 
expressing [U-15N]-labeled Grx1 and (b) the corresponding cell lysate. In the spectrum (a) the signals arising from Grx1 are not 
detected, due to the interaction with other cellular components. The two spectra were acquired with identical parameters; background 
subtraction was not performed. (c) Western Blot of the cell lysate analyzed in (b) (+) together with a control sample (–). 
 
 
Supplementary Figure 2 | Western Blots. Full Western Blots corresponding to (a) Fig. 3b and (b) Fig. 3d. An unrelated sample is 
marked with an asterisk. 
 
